TME Pharma N.V. (EPA:ALTME)
France flag France · Delayed Price · Currency is EUR
0.0640
-0.0004 (-0.62%)
Apr 25, 2025, 10:21 AM CET

TME Pharma Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2014 - 2018
Period Ending
Apr '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2014 - 2018
Market Capitalization
61217248
Upgrade
Market Cap Growth
-2.43%-26.24%-90.52%-28.42%221.14%-26.09%
Upgrade
Enterprise Value
31-54146
Upgrade
Last Close Price
0.060.231.1021.2150.9452.76
Upgrade
PS Ratio
---528.50696.1749.27
Upgrade
PB Ratio
3.87-4.15-1.303.873.17-4.09
Upgrade
P/TBV Ratio
3.88--3.873.16-
Upgrade
EV/Sales Ratio
---115.25394.4339.78
Upgrade
Debt / Equity Ratio
0.00-3.97-3.210.540.09-0.07
Upgrade
Asset Turnover
---0.000.010.05
Upgrade
Quick Ratio
1.970.820.761.813.580.42
Upgrade
Current Ratio
2.110.860.781.843.630.45
Upgrade
Return on Equity (ROE)
-901.00%--937.03%-236.93%-356.13%-
Upgrade
Return on Assets (ROA)
-109.50%-90.92%-100.06%-82.39%-58.78%-81.28%
Upgrade
Return on Capital (ROIC)
-187.55%-190.72%-153.93%-110.03%-109.87%-
Upgrade
Earnings Yield
-104.35%-552.35%-915.24%-82.86%-42.70%-11.35%
Upgrade
FCF Yield
-82.16%-463.63%-735.72%-71.07%-21.60%-56.70%
Upgrade
Buyback Yield / Dilution
-606.13%-326.62%-78.28%-103.92%-190.00%-180.42%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.